Biosintez

Biosintez is a prominent Russian pharmaceutical company headquartered in Penza, specializing in the manufacture of a diverse portfolio of generic medicines and active pharmaceutical ingredients. Established in 1955, the company has a long-standing history as a key supplier of antibiotics, blood substitutes, and various hospital-use drugs in the Russian market. Its product range includes over 180 items across multiple dosage forms such as tablets, ointments, powders for injection, and infusion solutions. In 2016, Biosintez was acquired by Sun Pharmaceutical Industries, a leading global specialty generic pharmaceutical company, which facilitated the modernization of its facilities and integration into international markets. The company operates large-scale manufacturing sites that adhere to Good Manufacturing Practice (GMP) standards and continues to play a critical role in the Russian healthcare system by providing affordable essential medicines.